|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:appearance
|
white crystalline powder
|
|
gptkbp:ATCCode
|
A12AA03
|
|
gptkbp:CASNumber
|
299-28-5
|
|
gptkbp:category
|
antidotes
electrolytes
calcium compounds
gluconates
mineral supplements
|
|
gptkbp:chemicalFormula
|
C12H22CaO14
|
|
gptkbp:contraindication
|
gptkb:hypercalcemia
gptkb:ventricular_fibrillation
|
|
gptkbp:discoveredBy
|
gptkb:Augustus_George_Vernon_Harcourt
|
|
gptkbp:discoveredIn
|
1882
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
calcium gluconate
|
|
gptkbp:KEGGID
|
D00262
|
|
gptkbp:MedlinePlus_ID
|
a682756
|
|
gptkbp:meltingPoint
|
201°C (decomposes)
|
|
gptkbp:molecularWeight
|
430.373 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEBI:31344
CHEMBL1201192
5460345
DB11126
|
|
gptkbp:routeOfAdministration
|
oral
topical
intravenous
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
nausea
constipation
bradycardia
|
|
gptkbp:solubility
|
3.5 g/100 mL (20°C)
|
|
gptkbp:UNII
|
SQE6VB453K
|
|
gptkbp:used_as_antidote_for
|
hydrofluoric acid burns
|
|
gptkbp:usedFor
|
treatment of calcium channel blocker overdose
treatment of hyperkalemia
treatment of hypermagnesemia
treatment of hypocalcemia
|
|
gptkbp:bfsParent
|
gptkb:Calcium
|
|
gptkbp:bfsLayer
|
4
|